CLINICAL_TRIALS
trial_result
· 2014-05-12
Clinical Trial Update: Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke [Phase 2]
Summary
This Phase 2 trial update reports safety and pharmacokinetic findings for MCI-186 (edaravone) in subjects with acute ischemic stroke.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Acute Ischemic Stroke (AIS) | Phase 2 | Status: COMPLETED | Results posted: 2014-05-12